MyFinsight
Home
Blog
About
Contact
Download
Download image
Cash and cash
equivalents
$28,201K
Prepaid expenses and
other current assets
$1,048K
Restricted cash, current
$729K
Inventories
$382K
Accounts receivable, net
of allowance for...
$157K
Total current assets
$30,517K
Machinery and equipment,
net, and...
$6,452K
Right-of-use operating and
financing lease assets,...
$2,459K
Other noncurrent
assets
$574K
Restricted cash,
noncurrent
$425K
Total assets
$40,427K
Accumulated deficit
-$405,051K
Total liabilities and
shareholders' deficit
$40,427K
Total shareholders'
deficit
-$10,691K
Common stock, no par
value, 230,000 shares...
$394,289K
Accumulated other
comprehensive income
$71K
Total liabilities
$51,118K
Contingent consideration
liabilities, noncurrent
$37,806K
Total current
liabilities
$12,005K
Operating and financing
lease liabilities,...
$1,307K
Accrued compensation
$3,333K
Due to related party
(note 9)
$2,736K
Operating and financing
lease liabilities,...
$1,762K
Accounts payable
$1,615K
Accrued expenses and
other current...
$1,284K
Accrued royalties
$1,116K
Contingent consideration
liabilities, current
$159K
Back
Back
Balance Sheet
Insight Molecular Diagnostics Inc. (IMDX)
Insight Molecular Diagnostics Inc. (IMDX)
source: myfinsight.com